Healthway

Healthway: Grp proposed a 1-for-8 non-underwritten rights issue of up to 230.6m shares at an issue price of 7.5c/share. If fully subscribed, grp will record $17.05m net proceeds. Proceeds will be used to fund the expansion of its network of medical centres and facilities in Spore, China and Asean, and also for general working capital. Based on yesterday’s closing price of $0.13, new enlarged share base could see share price trade at 0.12-0.125c.